MK
Mitchell Kapoor HC Wainwright & Co Latest Price Targets & Analyst Ratings
Main Sector
Healthcare
Ratings Past Year
150
Avg Return
Past Year
Past Year
15%
Success Rate
Past Year
Past Year
0
%
Rating Distribution
Past Year
Positive
81%
Neutral
14.4%
Negative
4.6%
Past Week
Past Month
Past 3 Months
Past 6 Months
Past Year
All Time
Positive
Neutral
Negative
Large Cap
$10B to $200B
Mid Cap
$2B to $10B
Small Cap
$250M to $2B
Micro Cap
Under $250M
Healthcare
Healthcare
Biotechnology
Drug Manufacturers - General
| Stock | Rating | Price Target |
Upside Downside |
Ratings 1 Year |
Avg Return 1 Year |
Success Rate 1 Year | Date | |
|---|---|---|---|---|---|---|---|---|
|
Buy
Reiterated
| $7 |
373%
upside
| 2 | +11% |
0
%
| 19 Aug ‘25 6 months ago |
|
|
|
Neutral
Maintained
| $2 |
71%
downside
| 2 | – |
–
| 19 Aug ‘25 6 months ago |
|
|
|
Buy
Maintained
| $4 |
254%
upside
| 2 | +1.4% |
0
%
| 11 Aug ‘25 6 months ago |
|
|
|
Neutral
Downgraded
| $13.50 |
21%
upside
| 3 | +103% |
0
%
| 18 Jun ‘25 8 months ago |
|
|
|
Neutral
Downgraded
| – | – | 2 | -60% |
0
%
| 9 Apr ‘25 11 months ago |
|
|
|
Buy
Reiterated
| $9 |
592%
upside
| 1 | -6.5% |
0
%
| 3 Apr ‘25 11 months ago |
|
|
|
Buy
Maintained
| $2 |
22%
downside
| 1 | +445% |
0
%
| 3 Apr ‘25 11 months ago |
|
|
|
Buy
Reiterated
| $15 |
209%
upside
| 1 | -5.8% |
0
%
| 24 Mar ‘25 11 months ago |
|